0 ERNA 2004 Scaling Up The Red Cross Red Crescent Response to Tuberculosis in Europe Region (strengthening the HIV/AIDS component) Krakow, 25-28 September,

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

UNITED NATIONS’ RESPONSE TO THE
International Security Security UNAIDS INITIATIVE ON HIV/AIDS AND SECURITY NationalSecurityNationalSecurityHumanitarianResponseHumanitarianResponse In.
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
Saving lives, changing minds. Collaborative TB/HIV services for people who use drugs The experience of Red Cross / Red Crescent Lasha Goguadze.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Engaging All Care Providers in S.E Asia Region A pproach to Health Systems Strengthening Jan Voskens. IUATLD Paris, 31 October 2006.
WHO global plans to expand the Structured Operational Research and Training Initiative program Dr Andrew Ramsay
TB and HIV: Tightly Linked… and Why We Should Care.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
Update Regional Task Force Hospitals and health facilities safe from disasters IAP meeting March
Race and Ethnicity.
MEASURE Evaluation M&E and Advocacy Tools in the response to the Emergency Declaration.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
1 Dr Carmelia Basri Dr Nadia Tarmizi National TB Control Program Indonesia M&E WORKSHOP MEASURE Evaluation, New Delhi, 1Feb2006.
Revised National Tuberculosis Control Programme (RNTCP)
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
Module 2: Overview and Background. Learning Objectives Part 1 –Describe TB global epidemiology –Explain 5-point DOTS strategy for effective TB control.
THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.
World Health Organization
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
The Second Stop TB Partners’ Forum Keynote address: Marcos Espinal Executive Secretary 24 March 2004 – New Delhi, India.
Regional Task Force Hospitals and Health Facilities Safe from Disasters IAP meeting 13 August 2009 Incheon.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
IPM: The World Customs Organization’s tool against Counterfeiting Knowledge Academy Brussels, 03/07/2014.
TAI Background: Relevant International Commitments governments sign the Rio Declaration. Principle 10 mandated appropriate access to information,
Afghanistan Albania Algeria Andorra Angola.
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Historical development ICC-TB recommends creating a Partnership in meeting, Sept 2004 WHO signed co-funding agreement with Federation Red Cross, Aug 2006.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
An Overview of TB in SAARC Countries and Role of SAARC TB Centre in TB Control Dr Paras K Pokharel, Associate Professor Dept. of Community Medicine, BPKIHS.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
Global MAX Welcome to the world of…. About us We take pleasure in inviting you to become a member of Global MAX. We have two objectives: 1 st to provide.
5 th Inter-Agency Meeting on Coordination and Harmonization of HIV/AIDS, TB and Malaria Strategies RECOMMENDATIONS OF THE EXPERT MEETING 5-7 MARCH 2014,BRAZZAVILLE,
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Dana Farcasanu Foundation Center for Health Policies and Services
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
HCT in the mining industry
Statistics and cooperation: an essential link Technical cooperation is a “core business” of Istat Claudia Cingolani Director, Office for International.
The role of prevalence surveys in measuring the burden of TB, progress in TB control and improving early case detection Ikushi Onozaki WHO/STB/TBS Global.
1 People Programme Marie Curie Actions International Research Staff Exchange Scheme IRSES Dr. Barbara Rhode European Commission Marie Curie Actions - Fellowships.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
The Bank’s Regional HIV/AIDS Strategies An Overview.
CENTENNIAL DECLARATION on the role of NGOs in Tuberculosis Control Dr. Maarten van Cleeff, Project Director TBCTA Keeping the Pledge Delhi, March 2003.
Global Tuberculosis Control 2007 Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
Community Representative Update
Activity of the High-Level Group for Partnership, Coordination and Capacity Building for Statistics for Agenda 2030 on Sustainable Development (HLG) Gulmira.
Prisons and TB in Europe
اپيدميولوژي و كنترل سِل
وضعیت بیماری سل در جهان، منطقه و ایران
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
بیماری سل TUBERCULOSIS
Andy Ramsay Overview of TDR February 2014 Andy Ramsay
Eastern Europe, Russia and Middle and South America
Key issues in DOTS implementation
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
Essential Drugs and Medicines Policy (EDM) World Health Organization
World Populations and Populations Pyramids Lab
5th DEWG meeting Conclusions
Collaborative TB/HIV activities in European Region
The STOP TB Strategy – 2009 VISION: A TB-free world
Current status – (1) Achievements Building strong political commitment
Status of TB Operations
Presentation transcript:

0 ERNA 2004 Scaling Up The Red Cross Red Crescent Response to Tuberculosis in Europe Region (strengthening the HIV/AIDS component) Krakow, September, 2004

1 Tuberculosis A Global Emergency million new TB cases every year TB kills 5,000 people a day – 2 million each year One third of the world’s population is infected with TB

2 STOP TB Partnership  DOTS strategy (Directly Observed Treatment, Short Course)  Global Targets: cure rate up to - 85% case Detection - 70%

3 The 5 components of the internationally recommended TB control strategy Political and financial commitment Case detection by sputum smear microscopy and culture of TB suspects Directly observed and standardized short-course anti-TB chemotherapy (DOTS) Regular, uninterrupted supply of all essential anti-TB drugs A standardized recording and reporting system TB Register World Health Organization Regional Office for Europe

4 Stop TB Partnership 2004 News March 2004, new Delhi – Meeting Participants from the Movement (Members of the Stop TB) - American Red Cross - Russian Red Cross - Secretariat

5 World Health Organization Lessons learned  DOTS – the most cost effective  Less progress in case detection target  Limited access to diagnostic (partly because of weak social mobilization)  Political commitment in some countries to be increased  Focus on institutional capacity building  Partnership to be expanded to private sector, civil society, communities  TB / HIV  Advocacy / social mobilization

6 Achievements & Aims 2001–2005  By 2001: National plans and increased commitments  By 2002: Accelerating detection rates to 37%  By 2005: 70/85 TB control targets

DOTS detection rate (%) Treatment success (%) Cambodia Oma n Sri Lanka Guatemala Peru Morocco Maldives Viet Nam Cuba Slovenia Solomon Is Uruguay Qata r Mongolia USA Morocco Tanzania Venezuela Djibouti Chile Nicaragua TARGET ZONE Bosnia & Hezegovina Hong Kong DR Congo El Salvador Fiji French Polynesia Italy Kazakhstan Kenya Kyrgyzstan Latvia Lebanon Malta Marshall Is Portugal St Lucia Samoa South Africa Tonga Tunisia Turks & Caicos Is

DOTS detection rate (%) Treatment success (%) TARGET ZONE 85 % 70 %

9 HIV/AIDS ALWAYS ON BOARD IN TUBERCULOSIS PROGRAMMES Is it so?

10 Summary HIV/TB L Corbett et al. Arch. Int. Med. In press. 2002

11 RC/RC in TB Control Programmes  Bulgaria  Russia  Ukraine  Moldova  Central Asia  Armenia  Azerbaijan (planned)  Romania (planned)  Macedonia (planned)  Georgia prisons (ICRC)  Azerbaijan prisons (ICRC)  Armenia prisons (ICRC)  Myanmar (GFATM)  Americas (Agreement between AmX and PAHO)  Africa – Integration TB and ART

12 30 pilot projects in Russia and Central Asia Number of defaulters decreased by 30% Increased number of cured patients (from 65% to 73% in Pskov) Positive impact on TB control Motivation to complete the treatment Less side effects due to improved nutrition (results of interviews of TB patients in CA) 70-90% of patients completed the treatment Knowledge increase on the disease (by 30-80%) Psychological support helped RC/RC expertize in managing and implementing programme Role of the RC/RC in health care structure

13  Partnership:  Role of the National Societies in TB working groups in respective countries  Information sharing between different partners  New partnership: Federation - Lilly  Involvement in MDR – TB (Kazakhstan, Russia)  From TB guidelines to TB Policy  Decision of the health commission to prepare the TB Policy.

14 Next Steps ?????  TB will not go away tomorrow  Red Cross Red Crescent – one of the major players in  Effective interventions exist  RC/RC can reach more people Importance of increased partnership inside of the Movement More focus on social mobilization and voluntary involvement in TB programmes Working on new monitoring tools and quality analysis of programmes  TB / HIV  Identify areas of mutual benefit  Better integration between TB and HIV programmes

15 For consideration in group works  If this is the level of what we do

16 For consideration in group works  If this is the level of the needs (MOH)

17 For consideration in group works  If this is the level we would like to achieve National Society Contribution

18 For consideration in group works  How do we get there ? In 20 years

19 For consideration in group works  Scaling up Strategy ? In 20 years In 2 yearsIn 5 years

20 For consideration in group works 2 ideas (suggestions) for each issue: -Ways to increase voluntary involvement, community mobilization in TB Programmes -Ways to integrate TB / HIV -Way to increase partnership